Literature DB >> 33546905

Impact of COVID-19 outbreak on urology surgical waiting lists and waiting lists prioritization strategies in the Post-COVID-19 era.

E García-Rojo1, C Manfredi2, R Santos-Pérez-de-la-Blanca3, Á Tejido-Sánchez3, B García-Gómez3, M Aliaga-Benítez4, J Romero-Otero3, A Rodriguez-Antolín3.   

Abstract

INTRODUCTION: The suspension of most elective surgeries during COVID-19 pandemic caused the lengthening of urology surgical waiting lists. The objective of this study is to evaluate the impact of COVID-19 pandemic on urology surgical waiting list in a high-volume hospital.
METHODS: An observational descriptive study was designed. All patients included in the urology surgical waiting list of our high-volume center on May 1st 2020 (46 days after the suspension of elective surgery) were analyzed. Baseline variables, priority on the waiting list, main urological disease, type of scheduled surgery, and waiting time were recorded. Other variables recorded were the presence of a urinary catheter, number of accesses to the emergency department, evidence of COVID-19 infection, number of deaths and their cause. The waiting time for each disease was compared with the time to surgery in 2019.
RESULTS: A total of 350 patients were included. The mean (SD) time on the waiting list was 97.33 (55.47) days. Priority 1 patients, who normally should undergo surgery within 30 days, were on the waiting list for a mean (SD) time of 60.51 (20.14) days. They were mainly patients with ureteral lithiasis (25.6%), high-risk or muscle-invasive bladder cancer (20.9%) and high-risk prostate cancer (13.9%). The mean waiting time had already significantly exceeded the mean time to surgery in 2019 for radical cystectomy (p = 0.04) and URS (p = 0.003).
CONCLUSIONS: The suspension of most elective surgeries due to COVID-19 had a significant impact on urology surgical waiting list of our high-volume center, especially in priority 1 group.
Copyright © 2021 AEU. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  COVID-19; Coronavirus; Lista de espera; SARS-CoV-2; Urology; Urología; Waiting list

Mesh:

Year:  2020        PMID: 33546905      PMCID: PMC7946567          DOI: 10.1016/j.acuro.2020.11.001

Source DB:  PubMed          Journal:  Actas Urol Esp (Engl Ed)        ISSN: 2173-5786


  17 in total

1.  Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade Groups.

Authors:  Anne Offermann; Silke Hohensteiner; Christiane Kuempers; Julika Ribbat-Idel; Felix Schneider; Finn Becker; Marie Christine Hupe; Stefan Duensing; Axel S Merseburger; Jutta Kirfel; Markus Reischl; Verena Lubczyk; Rainer Kuefer; Sven Perner
Journal:  Front Med (Lausanne)       Date:  2017-09-29

2.  Impact of COVID-19 on Urologists: Learning on the Go.

Authors:  Elsayed Desouky
Journal:  Eur Urol Focus       Date:  2020-05-06

3.  Medically Necessary, Time-Sensitive Procedures: Scoring System to Ethically and Efficiently Manage Resource Scarcity and Provider Risk During the COVID-19 Pandemic.

Authors:  Vivek N Prachand; Ross Milner; Peter Angelos; Mitchell C Posner; John J Fung; Nishant Agrawal; Valluvan Jeevanandam; Jeffrey B Matthews
Journal:  J Am Coll Surg       Date:  2020-04-09       Impact factor: 6.113

Review 4.  Telemedicine Online Visits in Urology During the COVID-19 Pandemic-Potential, Risk Factors, and Patients' Perspective.

Authors:  Katharina Boehm; Stefani Ziewers; Maximilian P Brandt; Peter Sparwasser; Maximilian Haack; Franziska Willems; Anita Thomas; Robert Dotzauer; Thomas Höfner; Igor Tsaur; Axel Haferkamp; Hendrik Borgmann
Journal:  Eur Urol       Date:  2020-04-27       Impact factor: 20.096

5.  Considerations in the Triage of Urologic Surgeries During the COVID-19 Pandemic.

Authors:  Kristian D Stensland; Todd M Morgan; Alireza Moinzadeh; Cheryl T Lee; Alberto Briganti; James W F Catto; David Canes
Journal:  Eur Urol       Date:  2020-04-09       Impact factor: 20.096

6.  The impact of the coronavirus disease 2019 pandemic on the utilisation of emergency urological services.

Authors:  Mariana Madanelo; Carlos Ferreira; Diogo Nunes-Carneiro; André Pinto; Maria Alexandra Rocha; Jorge Correia; Bernardo Teixeira; Gonçalo Mendes; Catarina Tavares; Sofia Mesquita; Avelino Fraga
Journal:  BJU Int       Date:  2020-06-14       Impact factor: 5.969

7.  The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China.

Authors:  David S Hui; Esam I Azhar; Tariq A Madani; Francine Ntoumi; Richard Kock; Osman Dar; Giuseppe Ippolito; Timothy D Mchugh; Ziad A Memish; Christian Drosten; Alimuddin Zumla; Eskild Petersen
Journal:  Int J Infect Dis       Date:  2020-01-14       Impact factor: 3.623

8.  Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection.

Authors:  Shaoqing Lei; Fang Jiang; Wating Su; Chang Chen; Jingli Chen; Wei Mei; Li-Ying Zhan; Yifan Jia; Liangqing Zhang; Danyong Liu; Zhong-Yuan Xia; Zhengyuan Xia
Journal:  EClinicalMedicine       Date:  2020-04-05

Review 9.  Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic.

Authors:  Christopher J D Wallis; Giacomo Novara; Laura Marandino; Axel Bex; Ashish M Kamat; R Jeffrey Karnes; Todd M Morgan; Nicolas Mottet; Silke Gillessen; Alberto Bossi; Morgan Roupret; Thomas Powles; Andrea Necchi; James W F Catto; Zachary Klaassen
Journal:  Eur Urol       Date:  2020-05-03       Impact factor: 20.096

10.  Re: Maria J. Ribal, Philip Cornford, Alberto Briganti, et al. European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.056: Metastatic Prostate Cancer and COVID-19: Do Current Data Allow Modification of Established Treatment Recommendations?

Authors:  Christian Thomas; Carsten Grüllich; Holger H H Erb
Journal:  Eur Urol Focus       Date:  2020-06-04
View more
  5 in total

1.  How the First Year of COVID-19 Affected Elective Pediatric Urology Patients: A Longitudinal Study Based on Waiting Lists and Surveys From 10 European Centers.

Authors:  Nikolai Juul; Aurélie Cazals; Aybike Hofmann; Virginia Amesty; Gilvydas Verkauskas; Barbara Dobrowolska-Glazar; Gundela Holmdahl; Maria Escolino; Jacques Birraux; Tamas Kovacs; Nicolas Kalfa; Magdalena Fossum
Journal:  Front Public Health       Date:  2022-04-28

2.  COVID-19 and prostate cancer: a complex scenario with multiple facets.

Authors:  Felice Crocetto; Luciana Buonerba; Luca Scafuri; Vincenzo Caputo; Biagio Barone; Antonella Sciarra; Antonio Verde; Armando Calogero; Carlo Buonerba; Giuseppe Di Lorenzo
Journal:  Future Sci OA       Date:  2021-11-23

3.  Impact of COVID-19 on Surgical Volume: Single-Center Experience from Addis Ababa, Ethiopia.

Authors:  Yonas Ademe; Abraham Genetu; Tsegazeab Laeke; Mulat Taye; Abebe Bekele
Journal:  Ethiop J Health Sci       Date:  2022-01

4.  A retrospective cohort study of bladder cancer following the COVID-19 pandemic: Are patients presenting with more aggressive disease?

Authors:  Steven Anderson; Kate Rigney; Leah Hayes; Paul Christopher Ryan; Vishwa Chaitanya; Prem Thomas Jacob; Mamoun Abdelrahman; Subhasis K Giri
Journal:  Ann Med Surg (Lond)       Date:  2022-08-18

5.  The Impact of COVID-19 on Surgical Training: the Past, the Present and the Future.

Authors:  Marina Yiasemidou
Journal:  Indian J Surg       Date:  2021-06-12       Impact factor: 0.437

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.